Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

European Journal of Clinical Investigation

Volumn 39, Issue 2, 2009, Pages 145-156

  Latella, G ^a   Vetuschi, A ^a,d   Sferra, R ^a,d   Zanninelli, G ^a   D'Angelo, A ^a   Catitti, V ^a   Caprilli, R ^b   Flanders, K C ^c   Gaudio, E ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

ECM; Fibrosis; Smad proteins; TGF ; TNBS induced colitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD3 ANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLORECTAL FIBROSIS; CONTROLLED STUDY; FEMALE; FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION;

ANIMALS; COLLAGEN; COLON; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROSIS; MALE; MICE; MICE, KNOCKOUT; RECTUM; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID;

EID: 58649088728     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02076.x     Document Type: Article

References (52)

1. Rieder F, Brenmoehl J, Leeb S, Scholmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007 56 : 130 9.
2. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, O'Connell PR. Fibrogenesis in Crohn's disease. Am J Gastroenterol 2007 102 : 439 48.
3. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004 10 : 55 60.
4. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 1999 277 : C1 19.
5. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts II. Intestinal subepithelial myofibroblasts. Am J Physiol Cell Physiol 1999 277 : C183 201.
6. Pucilowska JB, Williams KL, Lund PK, Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastroinest Liver Physiol 2000 279 : G653 9.
7. Vetuschi A, Sferra R, Latella G, D'Angelo A, Catitti V, Zanninelli G et al. Smad3-null mice lack Interstitial Cells of Cajal in the colonic wall. Eur J Clin Invest 2006 36 : 41 8.
8. McKaig BC, Hughes K, Tighe PJ, Mahida YR. Differential expression of TGF-β isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 2002 282 : C172 82.
9. Wells RG, Fibrogenesis V. TGF-β signaling pathways. Am J Physiol Gastrointest Liver Physiol 2000 279 : G845 50.
10. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003 425 : 577 84.
11. Roberts AB, Russo A, Felici A, Flanders KC. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann NY Acad Sci 2003 995 : 1 10.
12. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-β/smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001 276 : 17058 62.
13. Lakos G, Tacagawa S, Chen SJ, Ferreira AM, Han G, Wang XJ et al. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 2004 165 : 203 17.
14. Zhao J, Shi W, Wang YL, Chen H, Bringas P, Datto MB et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002 282 : L585 93.
15. Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K et al. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 2004 66 : 597 604.
16. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004 85 : 47 64.
17. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor β/smad signal in hepatic fibrogenesis. Gut 2007 56 : 284 92.
18. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci USA 2004 101 : 8687 92.
19. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003 125 : 178 91.
20. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002 99 : 3908 13.
21. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999 104 : 5 11.
22. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H et al. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999 18 : 1280 91.
23. Zanninelli G, Vetuschi A, Sferra R, D'Angelo A, Fratticci A, Continenza A et al. Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol 2006 12 : 1211 8.
24. Lawrance IC, Wu F, Leite AZA, Willis J, West GA, Fiocchi C et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kB. Gastroenterology 2003 125 : 1750 61.
25. Latella G, Sferra R, Vetuschi A, Zanninelli G, D'Angelo A, Catitti V et al. Prevention of colonic fibrosis by boswellia and scutellaria extracts in rats with TNBS-induced colitis. Eur J Clin Invest 2008 38 : 410 20.
26. Fichtner-Feigl S, Fuss IJ, Young CA, Watanabe T, Geissler EK, Schlitt HJ et al. Induction of IL-13 triggers TGF-β1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 2007 178 : 5859 70.
27. Sinha S, Hoofnagle MH, Kingston PA, McCanna ME, Owens GK. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cell from embryonic stem cells. Am J Physiol Cell Physiol 2004 287 : C1560 8.
28. Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends Immunol 2004 25 : 513 7.
29. Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J, Kolb M. TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 2005 175 : 5390 5.
30. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver disease: diagnosis and management. J Hepatol 2005 42 : S22 36.
31. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cell and TGF-β as major players and therapeutic targets. J Cell Mol Med 2006 10 : 76 99.
32. Beddy D, Mulsow J, Watson RW, Fitzpatrick JM, O'Connell PR. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 2006 93 : 1290 6.
33. Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR. Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg 2005 242 : 880 7.
34. Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis 2001 7 : 226 36.
35. Di Mola F, Friess H, Scheuren A, Di Sebastiano P, Graber H, Egger B et al. Transforming growth factor-βs and their signaling receptors are co-expressed in Crohn's disease. Ann Surg 1999 229 : 67 75.
36. Mourelle M, Salas A, Guarner F, Crespo E, Garcia-Lafuente A, Malagelada JR. Stimulation of transforming growth factor beta-1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 1998 114 : 519 26.
37. Wengrower D, Zanninelli G, Pappo O, Latella G, Sestieri M, Villanova A et al. Prevention of fibrosis in experimental colitis by Captopril: the role of TGF-β1. Inflamm Bowel Dis 2004 10 : 536 45.
38. Vallance BA, Gunawan MI, Hewlett B, Bercik P, Van Kampen C, Galeazzi F et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol 2005 289 : G116 28.
39. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992 102 : 1920 9.
40. McKaig BC, McWilliams D, Watson SA, Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 2003 162 : 1355 60.
41. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998 30 : 909 22.
42. di Mola FF, Di Sebastiano P, Gardini A, Innocenti P, Zimmermann A, Buchler MW et al. Differential expression of connective tissue growth factor in inflammatory bowel disease. Digestion 2004 69 : 245 53.
43. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993 90 : 770 4.
44. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998 393 : 786 90.
45. Yang X, Li C, Hu X, Deng C. The tumor suppressor Smad4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA 1998 95 : 3667 72.
46. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 1999 19 : 2495 504.
47. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998 94 : 703 14.
48. Werner S, Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 2006 17 : 157 71.
49. Di Sabatino A, Bukley M, Pickard KM, Morera R, Cazzola P, Corazza GR et al. Transforming Growth Factor-β signaling and matrix metalloproteinase pattern in intestinal strictures in Crohn's disease. Inflamm Bowel Dis 2006 12 (Suppl. 2 S22.
50. Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem 2005 280 : 36099 109.
51. Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, Ney DM et al. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am J Physiol Gastrointest Liver Physiol 2005 289 : G342 50.
52. Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol 2008 214 : 199 210.